Innovation in Child Neurology: Acadia’s Head of Rare Disease Shares What It Takes to Make a Breakthrough

Kathie Bishop, Ph.D., knows exactly what it takes to lead cutting-edge therapeutics for neurologic and rare diseases from research to development to changing lives for patients and their families.

She is the Senior Vice President, Chief Scientific Officer and Head of Rare Disease at Acadia Pharmaceuticals – a role that was created specifically for her when she joined the company nearly a year ago in January 2021.